Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

COL9A3 antibody (AA 501-528)

There are 4+ publications for this product available. The Rabbit Polyclonal anti-COL9A3 antibody is suitable to detect COL9A3 in samples from Human. It has been validated for WB.
Catalog No. ABIN1881221
$451.00
Plus shipping costs $50.00
Shipping to: United States
Delivery in 10 to 12 Business Days

Quick Overview for COL9A3 antibody (AA 501-528) (ABIN1881221)

Target

See all COL9A3 Antibodies
COL9A3 (Collagen, Type IX, alpha 3 (COL9A3))

Reactivity

  • 25
  • 11
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Host

  • 24
  • 2
Rabbit

Clonality

  • 25
  • 1
Polyclonal

Conjugate

  • 14
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This COL9A3 antibody is un-conjugated

Application

  • 15
  • 13
  • 4
  • 3
  • 1
Western Blotting (WB)

Clone

RB42519
  • Binding Specificity

    • 6
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 501-528

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogen

    This COL9A3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 501-528 amino acids from the Central region of human COL9A3.

    Isotype

    Ig Fraction
  • Application Notes

    WB: 1:1000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Expiry Date

    6 months
  • Videman, Saarela, Kaprio, Näkki, Levälahti, Gill, Peltonen, Battié: "Associations of 25 structural, degradative, and inflammatory candidate genes with lumbar disc desiccation, bulging, and height narrowing." in: Arthritis and rheumatism, Vol. 60, Issue 2, pp. 470-81, (2009) (PubMed).

    Karppinen, Daavittila, Solovieva, Kuisma, Taimela, Natri, Haapea, Korpelainen, Niinimäki, Tervonen, Ala-Kokko, Männikkö: "Genetic factors are associated with modic changes in endplates of lumbar vertebral bodies." in: Spine, Vol. 33, Issue 11, pp. 1236-41, (2008) (PubMed).

    Decramer, Bascands, Schanstra: "Non-invasive markers of ureteropelvic junction obstruction." in: World journal of urology, Vol. 25, Issue 5, pp. 457-65, (2007) (PubMed).

    Virtanen, Karppinen, Taimela, Ott, Barral, Kaikkonen, Heikkilä, Mutanen, Noponen, Männikkö, Tervonen, Natri, Ala-Kokko: "Occupational and genetic risk factors associated with intervertebral disc disease." in: Spine, Vol. 32, Issue 10, pp. 1129-34, (2007) (PubMed).

  • Target

    COL9A3 (Collagen, Type IX, alpha 3 (COL9A3))

    Alternative Name

    COL9A3

    Background

    This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. Mutations in this gene are associated with multiple epiphyseal dysplasia type 3.

    Molecular Weight

    63616

    NCBI Accession

    NP_001844

    UniProt

    Q14050
You are here:
Chat with us!